| ORIGINAL ARTICLE
|Year : 2012 | Volume
| Issue : 3 | Page : 165--175
Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on Quality of Life: A cross-sectional study
Guru Karthikeyan1, Divita Jumnani1, Rama Prabhu1, Udaya Kumar Manoor2, Sanjay Sudhakar Supe3
1 Srinivas College of Physiotherapy and Research Center, Mangalore, India
2 Department of Radiation Oncology, Bangalore Hospital, Bangalore, India
3 Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bangalore, India
Background: Fatigue is disabling and continuous phenomenon in cancer patients during and after various anticancer treatments which can continue for many years after treatment and definitely it has profound effect on Quality of Life (QOL). However, determining its severity is still underestimated among the cancer patients and also very few studies in the literature exist reporting on Cancer-Related Fatigue (CRF) among Indian population.
Aims: To find out the prevalence of rate of fatigue in cancer patient receiving various anti cancer therapies. To find out the relative impact of fatigue on QOL.
Materials and Methods: This cross-sectional observational study included a total 121 cancer patients receiving radiotherapy, chemotherapy, and concurrent chemo-radiation with the age group of above 15 years who fulfilled the inclusion and exclusion criteria. All the patients were assessed for severity of fatigue using Brief Fatigue Inventory (BFI) and for QOL using FACT-G scale while they were receiving the anticancer therapies as an in-patient in the regional cancer centers in Madhya Pradesh, India.
Results: The severe fatigue was more prevalent in chemotherapy [58/59 (98.30%)], and concurrent chemo-radiation (33/42 (78.57%)) as compared to radiotherapy (Moderate-9/20 (45%) and Severe-9/20 (45%)). Moderate correlations were exhibited between fatigue due to radiotherapy and QOL (r = -0.71, P < 0.01), whereas weak correlation was found between fatigue due to chemotherapy and concurrent chemo-radiation (r = -0.361, P < 0.01 and r = -0.453, P < 0.01, respectively).
Conclusion: Severity of fatigue was found more after chemotherapy and concurrent chemo-radiation therapy while impact on QOL was more after the radiotherapy.
Srinivas College of Physiotherapy and Research Center, Mangalore
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*